RxDoctor Payments Data

Andrzej Brzezinski, MD

Orthopaedic Surgery · Avenel, NJNPI 1518492461

Payments from drug & device makers

$9,105in general payments, 2019–2025

Across 69 payments — averaging $131.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medacta USA, Inc.$2K
  • Stryker$2K
  • Smith+Nephew$2K
  • Arthrex$1K
  • Seapearl East, Inc$1K
  • Paragon 28, Inc.$247
  • plus $384 from 6 others

What the payments were for

  • Travel & lodging$5,52061%
  • Food & beverage$2,38626%
  • Education$1,20013%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medacta USA, Inc.13$2,325
Stryker19$2,055
Smith+Nephew12$1,570
Arthrex13$1,324
Seapearl East, Inc1$1,200
Paragon 28, Inc.2$247
Medical Device Business Services, Inc.3$165
Zimmer Biomet2$85
Kairos Surgical Inc1$41
Polaris Technology Solutions LLC1$35
Exactech, Inc.1$30
Johnson & Johnson1$28

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,105 in reported general payments places this provider in the 70th percentile of 587 orthopaedic surgery providers in New Jersey.

See all orthopaedic surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$57,689
Medicare patients
140
Services billed
369

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib67$682
Meloxicam30$56
Ondansetron Hcl12$37

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Avenel

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →